Page last updated: 2024-10-27

fenoldopam and Breast Cancer

fenoldopam has been researched along with Breast Cancer in 1 studies

Fenoldopam: A dopamine D1 receptor agonist that is used as an antihypertensive agent. It lowers blood pressure through arteriolar vasodilation.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Ben-Jonathan, N1
Borcherding, DC1
Hugo, ER1

Reviews

1 review available for fenoldopam and Breast Cancer

ArticleYear
Dopamine Receptors in Breast Cancer: Prevalence, Signaling, and Therapeutic Applications.
    Critical reviews in oncogenesis, 2022, Volume: 27, Issue:2

    Topics: Animals; Breast Neoplasms; Dopamine; Female; Fenoldopam; Humans; Mice; Prevalence; Receptors, Dopami

2022